A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT ID: NCT06447662

This clinical trial is studying a new medication called PF-07934040 to understand how safe it is and how well it works for people with advanced solid tumors that have a specific genetic change know...

Recruiting

Phase: PHASE1 Conditions: Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms +1 more

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

NCT ID: NCT06516965

This clinical trial, called STOP-PN2, is studying a medication called povorcitinib to see how well it works for people with prurigo nodularis, a skin condition that causes severe itching and bumps ...

Recruiting

Phase: PHASE3 Conditions: Prurigo Nodularis

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT ID: NCT06959225

This clinical trial, called TRuE-HS1, is looking at the effectiveness and safety of a cream called ruxolitinib for treating people with hidradenitis suppurativa (HS), a painful skin condition. The ...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT ID: NCT05355701

This clinical trial is studying a new medicine called PF-07799933 to see how safe it is and how well it works for people with advanced solid tumors that have a specific gene change known as a "BRAF...

Recruiting

Phase: PHASE1 Conditions: Melanoma, Glioma +2 more

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

NCT ID: NCT06704724

This clinical trial is studying a new medicine called PF-07985045 to see how safe it is and how well it works in treating advanced solid tumors, which are lumps of abnormal cells in the body. The t...

Recruiting

Phase: PHASE1 Conditions: Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms +1 more

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

NCT ID: NCT05064540

The JAGUAR Trial is a research study looking at the effectiveness of new devices used to treat a condition called Abdominal Aortic Aneurysm (AAA). This condition involves a bulge in the aorta, the ...

Recruiting

Phase: NA Conditions: AAA, AAA - Abdominal Aortic Aneurysm

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT ID: NCT05519085

This clinical trial is investigating a new treatment combination for patients with relapsed or refractory multiple myeloma (RRMM), which means their cancer has returned or did not respond to previo...

Recruiting

Phase: PHASE3 Conditions: Relapsed or Refractory Multiple Myeloma

Psilocybin for Major Depressive Disorder (MDD)

NCT ID: NCT06308653

This clinical trial is studying the effects of a compound called Psilocybin on adults with Major Depressive Disorder (MDD), which is a serious condition that affects mood and can make daily life ve...

Recruiting

Phase: PHASE3 Conditions: Depressive Disorder, Major

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06417814

This clinical trial is investigating the effectiveness and safety of a new treatment called Dato-DXd, either on its own or combined with another drug called osimertinib, for patients with advanced ...

Recruiting

Phase: PHASE3 Conditions: Metastatic Non-small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT ID: NCT06516952

This clinical trial is studying a new medication called povorcitinib to see how well it helps people with prurigo nodularis, a condition that causes intense itching and skin bumps. The main goal is...

Recruiting

Phase: PHASE3 Conditions: Prurigo Nodularis

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

NCT ID: NCT05423717

This clinical trial is studying a medication called daridorexant to see how well it works and how safe it is for children and teenagers aged 10 to under 18 who have trouble sleeping, known as insom...

Recruiting

Phase: PHASE2 Conditions: Insomnia

A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)

NCT ID: NCT06941844

The Emerge trial is a research study looking at a new treatment called MM120 for people with Major Depressive Disorder (MDD). This study is in its final phase, which means it’s testing how well MM1...

Recruiting

Phase: PHASE3 Conditions: Major Depressive Disorder

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

NCT ID: NCT05065216

The ReMEDy2 Trial is a study looking at a new treatment called DM199 for patients who have had an acute ischemic stroke (AIS) and cannot receive standard treatments like clot-busting drugs or mecha...

Recruiting

Phase: PHASE2 Conditions: Stroke, Ischemic Stroke +1 more

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

NCT ID: NCT06357533

This clinical trial is studying a new treatment option for patients with advanced non-small cell lung cancer (NSCLC) that is not of the squamous type. The trial is testing a combination of two medi...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

NCT ID: NCT06784752

This clinical trial is studying a treatment called [177Lu]Lu-DOTA-TATE combined with a medication called octreotide for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs...

Recruiting

Phase: PHASE3 Conditions: Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Recruiting

Conditions: Lumbar Spinal Stenosis

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

NCT ID: NCT05024695

This clinical trial is looking at a new treatment called the MINIject™ implant from iSTAR Medical, which aims to help lower eye pressure in people with a condition known as primary open-angle glauc...

Recruiting

Phase: NA Conditions: Glaucoma

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

NCT ID: NCT06571045

This clinical trial, called EYE-RES-102, is looking at how well a new treatment called EYE103 works for people with diabetic macular edema (DME), a condition that can cause vision problems due to d...

Recruiting

Phase: PHASE2 Conditions: Diabetic Macular Edema (DME)

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

NCT ID: NCT06957080

This clinical trial is studying a new treatment called EYE103 for patients with Diabetic Macular Edema (DME), a condition that can cause vision loss in people with diabetes. The trial compares two ...

Recruiting

Phase: PHASE2 Conditions: Diabetic Macular Edema (DME)

Parkinson's Foundation PD GENEration Genetic Registry

NCT ID: NCT04994015

The Parkinson's Foundation PD GENEration Genetic Registry is a clinical trial focused on collecting genetic information related to Parkinson's Disease. This study aims to create a central database ...

Recruiting

Conditions: Parkinson's Disease

Main Menu

Clinical Trials in Fayetteville, Arkansas

73 Active Trials Found in Fayetteville

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Psilocybin for Major Depressive Disorder (MDD)

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Parkinson's Foundation PD GENEration Genetic Registry